What causes ventricular tachycardia (VT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Ventricular Tachycardia

Ventricular tachycardia (VT) is primarily caused by structural heart disease, with coronary artery disease and myocardial infarction being the most common underlying etiologies, followed by cardiomyopathies, electrolyte abnormalities, and genetic disorders. 1

Structural Heart Disease Causes

Ischemic Heart Disease

  • Coronary artery disease (CAD) - Most common cause of VT in adults
  • Prior myocardial infarction (MI) - Scar tissue creates substrate for reentry circuits
  • Acute myocardial ischemia - Can trigger VT through abnormal automaticity and injury currents 1

Cardiomyopathies

  • Dilated cardiomyopathy - Myocardial fibrosis creates arrhythmogenic substrate
  • Hypertrophic cardiomyopathy - Associated with myocardial disarray and fibrosis 1
  • Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Fibro-fatty replacement of myocardium
  • Infiltrative cardiomyopathies - Sarcoidosis, amyloidosis, hemochromatosis

Non-Structural Causes

Electrolyte Abnormalities

  • Hypocalcemia - Prolongs QT interval, destabilizes cardiac cell membranes 2
  • Hypokalemia - Increases risk of VT recurrence even after correction 3
  • Hypomagnesemia - Often coexists with other electrolyte disorders
  • Hyperkalemia - Particularly in advanced kidney disease

Medication-Related

  • Antiarrhythmic drugs - Particularly Class IA and IC agents (proarrhythmic effect)
  • QT-prolonging medications - Can induce torsades de pointes (polymorphic VT)
  • Stimulants - Cocaine, amphetamines, and other sympathomimetics 1

Genetic/Inherited Disorders

  • Long QT syndrome - Congenital or acquired
  • Brugada syndrome - Characteristic ECG pattern with ST elevation in V1-V3 1
  • Catecholaminergic polymorphic VT - Exercise-induced arrhythmia
  • Short QT syndrome - Rare but highly arrhythmogenic

Other Causes

  • Congenital heart disease - Post-surgical repair creates substrate for reentry
  • Myocarditis - Inflammation creates transient arrhythmogenic substrate
  • Idiopathic VT - Often originates from right ventricular outflow tract or left ventricular fascicles
  • Mechanical triggers - Catheter manipulation, trauma
  • Autonomic influences - Increased sympathetic tone

Pathophysiologic Mechanisms

VT occurs through several mechanisms 1:

  1. Reentry - Most common mechanism in structural heart disease

    • Requires anatomical obstacle (scar) or functional block
    • Creates circuit for self-perpetuating electrical activity
  2. Enhanced automaticity - Abnormal spontaneous depolarization

    • Common in acute ischemia and electrolyte disorders
  3. Triggered activity

    • Early afterdepolarizations - Associated with QT prolongation
    • Late afterdepolarizations - Associated with calcium overload states

High-Risk Features

Certain findings indicate higher risk for life-threatening VT 1:

  • Prior cardiac arrest or sustained VT
  • Family history of sudden cardiac death
  • Unexplained syncope
  • Severe left ventricular hypertrophy (≥30mm)
  • Abnormal blood pressure response to exercise
  • Nonsustained VT on monitoring

Clinical Pearls

  • VT should be considered in any wide-complex tachycardia until proven otherwise
  • Transient causes (electrolyte abnormalities, drug effects) should be corrected but don't eliminate risk of recurrence in patients with structural heart disease 1, 3
  • Polymorphic VT may have different causes than monomorphic VT, with medication effects and electrolyte disorders being more common 4
  • In young patients without obvious heart disease, consider genetic channelopathies and congenital anomalies 1

Remember that identifying and treating the underlying cause is essential for effective management of VT and prevention of sudden cardiac death.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hypocalcemia and Ventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.